Big pharma deals

CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Derived from Current Agreements, our editors have selected notable big pharma deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.

For comprehensive access to all life science deals as they are announced:

Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now

Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now

Featured big pharma deals

All big pharma deals: Deal Monitor | Current Agreements

Boehringer Ingelheim partners with Hydra Biosciences for small-molecule TRP inhibitors

April 14, 2015 : big pharma, Boehringer Ingelheim, partnering

Hydra Biosciences and Boehringer Ingelheim have entered into a worldwide research collaboration and license agreement to identify small-molecule TRP inhibitors more »

AstraZeneca partners with PatientsLikeMe

April 14, 2015 : AstraZeneca, big pharma, partnering

PatientsLikeMe and AstraZeneca have signed a five-year agreement to provide access to PatientsLikeMe’s global network in support of AstraZeneca’s patient-driven research initiatives more »

Roche acquires Capp Medical

April 14, 2015 : big pharma, M&A

Roche has acquired CAPP Medical, a genomics research company more »

BioXcel and Takeda in repurposing pact for rare diseases

April 13, 2015 : big pharma, partnering, Takeda

BioXcel has entered into a partnership with Takeda Development Center Americas for the repurposing of assets across the gamut of rare diseases more »

Sanofi Pasteur and VBI Vaccines in formulation pact

April 9, 2015 : big pharma, partnering, Sanofi

VBI Vaccines has entered into a research collaboration with Sanofi Pasteur to apply VBI’s LPV (Lipid Particle Vaccine) formulation technology more »

Merck and Arvinas in therapy alliance using Protac technology

April 9, 2015 : big pharma, Merck, partnering

Arvinas announced a strategic collaboration with Merck in which Arvinas’ novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics more »

BMS and UniQure in $1bn gene therapy pact

April 7, 2015 : big pharma, Bristol-Myers Squibb, partnering

Agreement provides Bristol-Myers Squibb with exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases more »

Merck and Syndax partner for cancer combo clinical

April 1, 2015 : big pharma, Merck, partnering

Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat, an investigational epigenetic therapy, with KEYTRUDA more »

Teva acquires Auspex for $3.2 billion

March 31, 2015 : big pharma, M&A, Teva

Teva and Auspex Pharmaceuticals have entered into a definitive merger agreement more »

Merck Serono and Intrexon in CAR-T cancer pact

March 31, 2015 : big pharma, Merck KGaA, Merck Serono, partnering

Intrexon and Merck Serono announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies more »

« Page 1, 2, 3, 4, 5 ... 124, »

Derived from Current Agreements, more featured partnering deals by category:

Big biotech

Medimmune licenses Omnis’ immuno-oncology program

January 13, 2015

Roche and Foundation Medicine in personalized meds for cancer pact

January 13, 2015

Roche acquires majority stake in Foundation Medicine

January 13, 2015

View more featured deals | all deals at Deal Monitor


Novan Therapeutics gains $50 million in private placement

March 31, 2015

Merck Serono and Intrexon in CAR-T cancer pact

March 31, 2015

Novartis and Aduro Biotech in immuno-oncology pact

March 31, 2015

View more featured deals | all deals at Deal Monitor


Pfizer acquires Redvax, gains promising CMV vaccine candidate

January 6, 2015

Moderna Therapeutics pulls in $450 million financing

January 6, 2015

Aduro Biotech gains $51.4 million series D financing

January 6, 2015

View more featured deals | all deals at Deal Monitor


Invitae raises $120 million in series F financing

October 14, 2014

Becton Dickinson gets $9.1 billion in loan financing

October 14, 2014

Roche has made acquisition of technology from AbVitro

October 10, 2014

View more featured deals | all deals at Deal Monitor

Medical device

Biolase have purchased $35 million in private financing

November 6, 2014

Quanta Fluid Solution gets fundrasing financing for $33.79 million

November 4, 2014

VytronUS raises $31.6 million in series B financing

October 30, 2014

View more featured deals | all deals at Deal Monitor

Drug delivery

The Medicines Company enters into m&a with Tenaxis

April 24, 2014

SkyePharma raises $186 million in public offering financing

April 1, 2014

Unilife pharma alliances with Novartis for drug delivery systems

December 4, 2013

View more featured deals | all deals at Deal Monitor

Print Friendly, PDF & Email